T4	Disorder 182 211	Plasmodium falciparum malaria
N1 	Reference T4 UMLS:C0024535	Plasmodium falciparum malaria
T5	Pharmacological_substance 213 236	Artemether-lumefantrine
N1000 	Reference T5 MeSH:C515298	Artemether-lumefantrine
T7	Disorder 270 291	uncomplicated malaria
N2 	Reference T7 UMLS:C0024530	uncomplicated malaria
T8	Pharmacological_substance 373 385	lumefantrine
N1001 	Reference T8 MeSH:C102070	lumefantrine
T9	Pharmacological_substance 522 534	lumefantrine
N1002 	Reference T9 MeSH:C102070	lumefantrine
T10	Disorder 576 583	malaria
N3 	Reference T10 UMLS:C0024530	malaria
T11	Disorder 712 741	Plasmodium falciparum malaria
N4 	Reference T11 UMLS:C0024535	Plasmodium falciparum malaria
T12	Pharmacological_substance 906 918	lumefantrine
N1003 	Reference T12 MeSH:C102070	lumefantrine
T13	Pharmacological_substance 1062 1074	lumefantrine
N1004 	Reference T13 MeSH:C102070	lumefantrine
T16	Pharmacological_substance 1331 1343	lumefantrine
N1005 	Reference T16 MeSH:C102070	lumefantrine
T20	Pharmacological_substance 1703 1715	lumefantrine
N1006 	Reference T20 MeSH:C102070	lumefantrine
T21	Disorder 1744 1751	malaria
N5 	Reference T21 UMLS:C0024530	malaria
T1	Pharmacological_substance 93 116	artemether-lumefantrine
N1007 	Reference T1 MeSH:C515298	artemether-lumefantrine
T2	Subject 66 82	African children
T23	Pharmacological_substance 34 46	lumefantrine
N1008 	Reference T23 MeSH:C102070	lumefantrine
T25	Subject 441 449	children
T26	Subject 554 570	African children
T28	Subject 662 686	899 infants and children
T30	Subject 969 981	621 patients
T19	Subject 1730 1738	children
T36	Pharmacological_substance 764 766	AL
N1009 	Reference T36 MeSH:D000535	AL
T37	Pharmacological_substance 1642 1644	AL
N1010 	Reference T37 MeSH:D000535	AL
T38	Pharmacological_substance 238 240	AL
N1011 	Reference T38 MeSH:D000535	AL
T39	Pharmacological_substance 149 156	Coartem
N1012 	Reference T39 MeSH:C515298	Coartem
